Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes

Anemia is the defining feature in most patients with myelodysplastic syndromes (MDS), yet defects in erythropoiesis have not been well characterized. We examined freshly obtained bone marrow (BM) samples for stage-specific abnormalities during terminal erythroid differentiation (TED) from 221 sample...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Ali, Abdullah Mahmood, Huang, Yumin, Pinheiro, Ronald Feitosa, Xue, Fumin, Hu, Jingping, Iverson, Nicholas, Hoehn, Daniela, Coutinho, Diego, Kayani, Jehanzeb, Chernak, Brian, Lane, Joseph, Hillyer, Christopher, Galili, Naomi, Jurcic, Joseph, Mohandas, Narla, An, Xiuli, Raza, Azra
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Myeloid Neoplasia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6020814/
https://ncbi.nlm.nih.gov/pubmed/29903708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018018440
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados